Daratumumab in multiple myeloma von Nooka, Ajay K., Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Heffner, Thomas L., Gupta, Vikas A., Sullivan, Harold C., Neish, Andrew S., Dhodapkar, Madhav V., Lonial, Sagar

Volltext

Game of Bones: How Myeloma Manipulates Its Microenvironment von Moser-Katz, Tyler, Joseph, Nisha S., Dhodapkar, Madhav, Lee, Kelvin P., Boise, Lawrence H.

Volltext

Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy von Robinson, M Hope, Villa, Nancy Y, Jaye, David L, Nooka, Ajay K, Duffy, Alyssa, McCachren, Samuel S, Manalo, Julia, Switchenko, Jeffrey M, Barnes, Sierra, Potdar, Sayalee, Azeem, Maryam I, Horvat, Ava A, Parihar, Vaunita C, Gong, Jingjing, Liang, Yan, Smith, Geoffrey H, Gupta, Vikas A, Boise, Lawrence H, Kaufman, Jonathan L, Hofmeister, Craig C, Joseph, Nisha S, Lonial, Sagar, Dhodapkar, Kavita M, Dhodapkar, Madhav V

Volltext

Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience von Maples, Kathryn T., Hall, Kevin H., Joseph, Nisha S., Hofmeister, Craig C., Gupta, Vikas, Dhodapkar, Madhav V., Kaufman, Jonathan L., Nooka, Ajay K., Lonial, Sagar

Volltext

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience von Scott, Sara A., Marin, Ellen M., Maples, Kathryn T., Joseph, Nisha S., Hofmeister, Craig C., Gupta, Vikas A., Dhodapkar, Madhav V., Kaufman, Jonathan L., Lonial, Sagar, Nooka, Ajay K.

Volltext

Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab... von Joseph, Nisha S., Kaufman, Jonathan L., Gupta, Vilas A., Hofmeister, Craig C., Dhodapkar, Madhav V., Boise, Lawrence H., DiCamillo, Sara M., Roberts, Danielle, Nooka, Ajay K., Lonial, Sagar

Volltext

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity von Moreno, Alberto, Manning, Kelly, Azeem, Maryam I., Nooka, Ajay K., Ellis, Madison, Manalo, Renee Julia, Switchenko, Jeffrey M., Wali, Bushra, Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Dhodapkar, Kavita M., Dhodapkar, Madhav V., Suthar, Mehul S.

Volltext

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma von Joseph, Nisha S., Kaufman, Jonathan L., Dhodapkar, Madhav, Hofmeister, Craig C., Almaula, Dhwani K., Heffner, Leonard T., Gupta, Vikas A., Boise, Lawrence H., Lonial, Sagar, Nooka, Ajay K.

Volltext

Venetoclax ex vivo functional profiling predicts improved progression-free survival von Gupta, Vikas A., Matulis, Shannon M., Barwick, Benjamin G., Bog, R. Devin, Shebelut, Conrad W., Shanmugam, Mala, Neri, Paola, Bahlis, Nizar J., Dhodapkar, Madhav V., Heffner, Leonard T., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Kaufman, Jonathan L., Jaye, David L., Nooka, Ajay K., Boise, Lawrence H.

Volltext

Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re‐treatment with daratumumab among refractory patient... von Nooka, Ajay K., Joseph, Nisha S., Kaufman, Jonathan L., Heffner, Leonard T., Gupta, Vikas A., Gleason, Charise, Boise, Lawrence H., Lonial, Sagar

Volltext

“I took the road less traveled, and that has made all the difference”: Making a case for high‐dose therapy and autologous stem cell transplantation in elderly patients with newly d... von Nooka, Ajay K., Joseph, Nisha S., Lonial, Sagar

Volltext

How to rescue a DreaMM deferred von Joseph, Nisha S., Lonial, Sagar

Volltext

Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression von Gupta, Vikas A., Barwick, Benjamin G., Matulis, Shannon M., Shirasaki, Ryosuke, Jaye, David L., Keats, Jonathan J., Oberlton, Benjamin, Joseph, Nisha S., Hofmeister, Craig C., Heffner, Leonard T., Dhodapkar, Madhav V., Nooka, Ajay K., Lonial, Sagar, Mitsiades, Constantine S., Kaufman, Jonathan L., Boise, Lawrence H.

Volltext

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma von Nooka, Ajay K., Shanmugasundaram, Uma, Cheedarla, Narayana, Verkerke, Hans, Edara, Venkata V., Valanparambil, Rajesh, Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Azeem, Maryam, Manalo, Julia, Switchenko, Jeffrey M., Chang, Andres, Linderman, Susanne L., Roback, John D., Dhodapkar, Kavita M., Ahmed, Rafi, Suthar, Mehul S., Neish, Andrew S., Dhodapkar, Madhav V.

Volltext

Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents von Mina, Roberto, Joseph, Nisha S., Kaufman, Jonathan L., Gupta, Vikas A., Heffner, Leonard T., Hofmeister, Craig C., Boise, Lawrence H., Dhodapkar, Madhav V., Gleason, Charise, Nooka, Ajay K., Lonial, Sagar

Volltext

High-risk Multiple Myeloma: Definition and Management von Joseph, Nisha S., Gentili, Silvia, Kaufman, Jonathan L., Lonial, Sagar, Nooka, Ajay K.

Volltext

Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant von Sivakumar, Akhilesh, Bryson, Evan B., Hall, Kevin H., Maples, Kathryn T., Goyal, Subir, Joseph, Nisha S., Hofmeister, Craig C., Kaufman, Jonathan L., Lonial, Sagar, Nooka, Ajay K., Harvey, Robert Donald

Volltext

Natural history of multiple myeloma patients refractory to venetoclax: A single center experience von Maples, Kathryn T., Nooka, Ajay K., Gupta, Vikas, Joseph, Nisha S., Heffner, Leonard T., Hofmeister, Craig, Dhodapkar, Madhav, Matulis, Shannon M., Lonial, Sagar, Boise, Lawrence H., Kaufman, Jonathan L.

Volltext

Approaches to Treating Multiple Myeloma, Now and Moving Forward von Gupta, Vikas A., Joseph, Nisha S., Nooka, Ajay K.

Volltext

Novel Approaches for the Management of AL Amyloidosis von Joseph, Nisha S., Kaufman, Jonathan L.

Volltext